Remove FDA Remove Health and Personal Care Stores Remove Mail-Order Pharmacies
article thumbnail

Pharmacists Can Now Dispense Mifepristone Under Updated REMS Program

Birth Control Pharmacist

As of January 2023, the US Food and Drug Administration (FDA) announced an update to the Risk Evaluation and Mitigation Strategy (REMS) for mifepristone. This update is expected to alleviate the burden on patients and make medication abortion care more accessible. The other component of the medication abortion regimen is misoprostol.

article thumbnail

STAT+: Pharmalittle: FDA rule change allows pharmacies to offer abortion pills; Medicare could have saved billions if inflationary rebate law existed

STAT

Balmy breezes and clear blue skies are enveloping the Pharmalot campus, where the official mascot is eagerly awaiting his first constitutional of the day and the short person is sleeping in. Top of the morning to you, and a fine one it is. Continue to STAT+ to read the full story…